Antisense oligonucleotide modulation of STAT3 expression

Details for Australian Patent Application No. 2011201027 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Karras, James G.

Agent Spruson & Ferguson

Pub. Number AU-A-2011201027

Parent 2004316504

Filing date 8 March 2011

Wipo publication date 31 March 2011

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

31 March 2011 Application Open to Public Inspection

  Published as AU-A-2011201027

31 March 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011201028-An improved CO2 absorption solution

2011201026-Piroplasmid vaccine